A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nintedanib Impurity 20 | CAS 1912-28-3 - Request Quote

Picture of Nintedanib Impurity 20

Nintedanib Impurity 20

SZ CAT No:SZ-N023031
CAS No
1912-28-3
Mol.F.
C3H8O3S
Mol.Wt.
124.2
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Nintedanib Impurity 20 is chemically Methyl ethanesulfonate. Nintedanib Impurity 20 is supplied with detailed characterization data compliant with regulatory guideline. Nintedanib Impurity 20 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nintedanib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1912-28-3

Purchase 1912-28-3

Order 1912-28-3

Enquire 1912-28-3

price of 1912-28-3

1912-28-3 Supplier

1912-28-3 Manufacturer

1912-28-3 Exporter

buy high quality Nintedanib Impurity 20

Purchase Nintedanib Impurity 20

Nintedanib Impurity 20 suppliers

Nintedanib Impurity 20 manufacturers

Nintedanib Impurity 20 price

Order Nintedanib Impurity 20

Enquire Nintedanib Impurity 20

Nintedanib Impurity 20 cost

Nintedanib Impurity 20 Supplier

Nintedanib Impurity 20 Distributor

Nintedanib Impurity 20 for Method Validation

Nintedanib Reference Standard

Nintedanib Impurity 20 for ANDA Filing

Nintedanib Impurity 20 for Forced Degradation Studies

Nintedanib Impurity 20 Identification Standards

Nintedanib Impurity 20 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,